Novel N-oxide of naphthalimides as prodrug leads against hypoxic solid tumor: Synthesis and biological evaluation

  • Hong Yin
  • , Yufang Xu*
  • , Xuhong Qian
  • , Yuanli Li
  • , Jianwen Liu
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

Novel tertiary amine N-oxides of naphthalimides were designed and synthesized as potential anticancer agents against hypoxic solid tumors. Although their ctDNA-binding affinities and cytotoxic activities against usual tumor cell lines were lower than those of corresponding amines, the N-oxides A1 and A4 showed hypoxia preference activities against A375 cells in vitro and might be used as interesting candidates of prodrug leads in hypoxic tumor cells.

Original languageEnglish
Pages (from-to)2166-2170
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume17
Issue number8
DOIs
StatePublished - 15 Apr 2007
Externally publishedYes

Keywords

  • Biological evaluation
  • Hypoxic solid tumor
  • N-Oxide of naphthalimides
  • Prodrug leads
  • Synthesis

Fingerprint

Dive into the research topics of 'Novel N-oxide of naphthalimides as prodrug leads against hypoxic solid tumor: Synthesis and biological evaluation'. Together they form a unique fingerprint.

Cite this